Risk Factors for Amoxicillin-Clavulanate Resistance in Community-Onset Urinary Tract Infections Caused by
Enterobacterales
amoxicillin/clavulanate
antimicrobial resistance
emergency department
fluoroquinolones
urinary tract infection (UTI)
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
14 May 2021
14 May 2021
Historique:
received:
11
04
2021
revised:
26
04
2021
accepted:
10
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
High rates of amoxicillin-clavulanate (AMC) resistance among Enterobacterales isolated from urinary tract infections (UTIs) were observed in our area. The aim of this study was to identify risk factors associated with AMC resistance in patients with community-onset UTI in emergency departments (EDs). A retrospective study was performed of all ED patients with positive urine cultures for 330 urine cultures in all were included: 261 (79.1%) for Prior antibiotic exposure, particularly to AMC or fluoroquinolones, was the only independent risk factor associated with development of AMC resistance in
Sections du résumé
BACKGROUND
BACKGROUND
High rates of amoxicillin-clavulanate (AMC) resistance among Enterobacterales isolated from urinary tract infections (UTIs) were observed in our area. The aim of this study was to identify risk factors associated with AMC resistance in patients with community-onset UTI in emergency departments (EDs).
METHODS
METHODS
A retrospective study was performed of all ED patients with positive urine cultures for
RESULTS
RESULTS
330 urine cultures in all were included: 261 (79.1%) for
CONCLUSIONS
CONCLUSIONS
Prior antibiotic exposure, particularly to AMC or fluoroquinolones, was the only independent risk factor associated with development of AMC resistance in
Identifiants
pubmed: 34069184
pii: antibiotics10050582
doi: 10.3390/antibiotics10050582
pmc: PMC8156637
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int J Antimicrob Agents. 2005 Nov;26(5):380-8
pubmed: 16243229
Clin Microbiol Rev. 2006 Apr;19(2):382-402
pubmed: 16614254
J Antimicrob Chemother. 2002 Feb;49(2):367-71
pubmed: 11815581
Trends Microbiol. 2014 Aug;22(8):438-45
pubmed: 24842194
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
PLoS Pathog. 2009 Aug;5(8):e1000541
pubmed: 19662169
Ann Med. 2007;39(3):162-76
pubmed: 17457715
Front Microbiol. 2016 Jul 07;7:1017
pubmed: 27458434
Pharmacotherapy. 1984 May-Jun;4(3):122-36
pubmed: 6739312
Bull World Health Organ. 2007 Nov;85(11):867-72
pubmed: 18038077
BMC Infect Dis. 2018 Jan 26;18(1):56
pubmed: 29373965
Acad Emerg Med. 2014 Jan;21(1):17-24
pubmed: 24552520
Ann Intern Med. 2002 Nov 19;137(10):791-7
pubmed: 12435215
Int J Antimicrob Agents. 2011 Dec;38 Suppl:64-70
pubmed: 22018988
Emerg Med Clin North Am. 2018 Nov;36(4):685-710
pubmed: 30296999
Clin Infect Dis. 2011 Mar 1;52(5):e103-20
pubmed: 21292654
Virulence. 2019 Dec;10(1):260-276
pubmed: 30938219
Antimicrob Agents Chemother. 2012 Jul;56(7):3576-81
pubmed: 22491692
Front Microbiol. 2020 Feb 25;11:271
pubmed: 32158437
J Clin Microbiol. 2004 Jun;42(6):2701-6
pubmed: 15184455
Infection. 2011 Aug;39(4):333-40
pubmed: 21706226
Eur J Clin Microbiol Infect Dis. 2004 Mar;23(3):163-7
pubmed: 14986159
Clin Microbiol Rev. 2019 Nov 13;33(1):
pubmed: 31722889
J Antimicrob Chemother. 2001 Mar;47(3):305-13
pubmed: 11222563
JAMA. 1993 Dec 22-29;270(24):2957-63
pubmed: 8254858
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28971876
FEMS Microbiol Rev. 2012 Mar;36(2):340-63
pubmed: 21707670
Antimicrob Agents Chemother. 2012 Jul;56(7):3898-904
pubmed: 22526317